Rob Stein Rob Stein is a Correspondent and Senior Editor on NPR's Science Desk.
Rob Stein, photographed for NPR, 22 January 2020, in Washington DC.
Stories By

Rob Stein

FDA officials authorize Moderna and J&J COVID vaccine boosters

  • Download
  • <iframe src="https://www.npr.org/player/embed/1047891566/1047891567" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

The availability of COVID-19 boosters may soon expand dramatically

  • Download
  • <iframe src="https://www.npr.org/player/embed/1046952416/1046952417" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

People who got the Moderna vaccine may soon be eligible for COVID boosters

  • Download
  • <iframe src="https://www.npr.org/player/embed/1046279371/1046279372" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

NIH study of COVID-19 vaccine boosters suggests Moderna or Pfizer works best

  • Download
  • <iframe src="https://www.npr.org/player/embed/1045904225/1045904226" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

A study by the National Institutes of Health this week suggests people who got the J&J vaccine as their initial vaccination against the coronavirus may get their best protection from choosing an mRNA vaccine as the booster. Francine Orr/Los Angeles Times/Getty Images hide caption

toggle caption
Francine Orr/Los Angeles Times/Getty Images

A study of COVID vaccine boosters suggests Moderna or Pfizer works best

  • Download
  • <iframe src="https://www.npr.org/player/embed/1045485935/1045747534" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

The FDA may authorize more booster shots and is assessing a pill to treat COVID-19

  • Download
  • <iframe src="https://www.npr.org/player/embed/1045380505/1045380512" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Moderna and Johnson & Johnson release documents about COVID vaccine boosters

  • Download
  • <iframe src="https://www.npr.org/player/embed/1045260363/1045279195" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Gene-Editing Experiment Improves Sight In Patients With Impaired Vision

  • Download
  • <iframe src="https://www.npr.org/player/embed/1041443154/1041468398" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Carlene Knight, who has a congenital eye disorder, volunteered to let doctors edit the genes in her retina using CRISPR. Franny White/OHSU hide caption

toggle caption
Franny White/OHSU

A Gene-Editing Experiment Let These Patients With Vision Loss See Color Again

  • Download
  • <iframe src="https://www.npr.org/player/embed/1040879179/1041625426" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Winter Could Usher In Some Normalcy If Delta Surge Projections Are Correct

  • Download
  • <iframe src="https://www.npr.org/player/embed/1040550731/1040550732" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

CDC Director Walensky Overrules Advisers On Boosters For At-Risk Workers

  • Download
  • <iframe src="https://www.npr.org/player/embed/1040353433/1040353434" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

The pandemic appears to have peaked or be on the verge of peaking, with cases projected to slowly decline this fall and winter. As recently as Sept. 8, people were waiting at COVID-19 testing site in Kentucky, where over 4,000 new cases were confirmed that day. Jeffrey Dean/Bloomberg via Getty Images hide caption

toggle caption
Jeffrey Dean/Bloomberg via Getty Images

Is The Worst Over? Models Predict A Steady Decline In COVID Cases Through March

  • Download
  • <iframe src="https://www.npr.org/player/embed/1039272244/1039565571" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Johnson & Johnson Says Booster Shot Makes Their COVID Vaccine More Effective

  • Download
  • <iframe src="https://www.npr.org/player/embed/1039393888/1039393889" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

J&J Says Its Booster Shot Provides Increased Protection From COVID-19

  • Download
  • <iframe src="https://www.npr.org/player/embed/1039191206/1039191207" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Researchers say all three authorized COVID vaccines are good at keeping people out of the hospital, but Moderna seems to have the longest-lasting protection. Frederic J. Brown/AFP via Getty Images hide caption

toggle caption
Frederic J. Brown/AFP via Getty Images